Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
Clinical trial NCT04706598 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04706598
- Sponsor
- Fudan University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2024-07-11
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.